BIO-Europe Spring® 2016: AZ BioVenture Hub CEO says aim is an innovative ecosystem

June 21, 2016
AstraZeneca’s BioVentureHub CEO Magnus Björsne tells Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about the exchange's intention to generate a climate of open innovation to help grow and nurture the Scandinavian life science ecosystem. AZ BioVentureHub was established in 2014 in Gothenberg, Sweden, aimed at emerging biotech and medtech businesses and academic groups and already has attracted 18 companies, one academic group, four external sponsors and two scientific partners.
Previous Article
Single-use technology means big cost savings for bioprocessing industry
Single-use technology means big cost savings for bioprocessing industry

What does adoption of single-use technology mean for the bioprocessing industry?   The R&D and manufacturin...

Next Article
Surviving as a CMO
Surviving as a CMO

  What are the key factors for survival as a CMO today? Nordic Life Science has spoken to some Nordic CMOs ...